Ali Tafazzoli Selected Research

Alzheimer Disease (Alzheimer's Disease)

9/2022	The Potential Economic Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
6/2022	Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
10/2021	Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali Tafazzoli Research Topics

Disease

4	Heart Failure 02/2024 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 09/2022 - 10/2021
2	Dementia (Dementias) 06/2022 - 01/2018
2	Systolic Heart Failure 01/2017 - 01/2016
1	Neoplasms (Cancer) 11/2022
1	Disease Progression 06/2022
1	Cognitive Dysfunction 06/2022
1	Relapsing-Remitting Multiple Sclerosis 01/2020

Drug/Important Bio-Agent (IBA)

2	empagliflozinIBA 02/2024 - 12/2023
2	lecanemabIBA 09/2022 - 06/2022
2	IvabradineIBA 01/2017 - 01/2016
1	Complement System Proteins (Complement)IBA 11/2022
1	Cladribine FDA LinkGeneric 01/2020
1	TabletsIBA 01/2020

Therapy/Procedure

2	Therapeutics 10/2021 - 01/2016
1	Institutionalization (Institutionalized Persons) 01/2018
1	Patient Readmission 01/2017